^* This epilogue is adapted from: Kim JY, Farmer P. AIDS in 2006: moving toward one world, one hope? New England Journal of Medicine, August 17, 2006.

¹ United Nations General Assembly Special Session on HIV/AIDS. Declaration of commitment on HIV/AIDS: global crisis-global action. New York: United Nations, 2001. Accessed July 19, 2006 at: http://www.un.org/ga/aids/coverage/FinalDeclarationHIVAIDS.html.

² World Health Organization. Table 3.1. Chapter 3: HIV/AIDS: confronting a killer. World Health Report 2003. Geneva: World Health Organization, 2003:45.

³ Joint United Nations Program on HIV/AIDS, World Health Organization. AIDS epidemic update 2002. Geneva: UNAIDS, 2002.

⁴ Walensky RP, Paltiel AD, Losina E, et al. The survival benefits of AIDS treatment in the United States. J Infect Dis 2006;194:11-9.

⁵ Kim JY, Gilks C. Scaling up treatment—why we can’t wait. N Engl J Med 2005;353:2392–4.

⁶ Kim JY, Shakow A, Castro A, et al. Tuberculosis control. In: Smith R, Beaglehole R, Woodward D, Drager N, eds. Global public goods for health: health economic and public health perspectives. New York: Oxford University Press for the World Health Organization, 2003:54–72.

⁷ Vasan A, Hoos D, Mukherjee JS, et al. Pricing and procurement of antiretroviral drugs: lessons from the Global Fund. Bull World Health Organ 2006;84:393–8.

⁸ Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000–2004. MMWR 2006;55:301–5.

⁹ Gupta R, Kim JY, Espinal MA, et al. Responding to market failures in tuberculosis control. Science 2001;293:1049–51.

¹⁰ Gupta R, Irwin A, Raviglione MC, Kim JY. Scaling up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis. Lancet 2004;363:322–4.